Australia's largest stock trading and investment forum Australia's #1 stock forum

Biotechnology News

Mesoblast falls -10% on earnings report; -US$100M loss

Mesoblast had HotCopper users divided on whether the company's fortunes are anything to worry about based on the nature of a Friday webcast.

Jonathon Davidson

6 days ago

ASX News Healthcare Biotechnology

Telix (ASX:TLX) has experienced a jolt in its recovery after its quarterly – now, the FDA has knocked back an investigational PET scan agent.

Jonathon Davidson

28 Aug 2025 10:41 (AEST)

ASX News Healthcare Biotechnology

HotCopper sat down with Neurizon Therapeutics MD Michael Thurn to discuss the clinical-stage biotech company's latest NUZ-001 OLE study.

21 Aug 2025 14:57 (AEST)

ASX News The Watchlist Healthcare Biotechnology

Earnings day hasn’t quite been a shining one for CSL Ltd (ASX:CSL), with the $117 billion biotechnology bluechip unveiling plans to trim its global workforce by as much as 15% as it looks to save $550 million annually.Listen to the HotCopper podcast for in-depth discussions and in...

19 Aug 2025 11:36 (AEST)

ASX 200 ASX News Healthcare Biotechnology

Tetratherix (ASX:TTX) has jumped +3% heading into lunchtime trades as the company secures a $3.3M government...

Jonathon Davidson

14 Aug 2025 13:54 (AEST)

ASX News Healthcare Biotechnology

The Recce 327 Topical Gel is @highly effective” for treating infected burn wounds @ and it works quickly too @ Recce Pharmaceuticals (ASX:RCE) confirmed in ongoing tests, setting the stage for a U.S. Defence partnership.Listen to the HotCopper podcast for in-depth discussion...

14 Aug 2025 10:00 (AEST)

ASX News The Watchlist Healthcare Biotechnology

Recce Pharma (ASX:RCE) has notched modest gains in the Tuesday arvo session after reporting its R327 anti-infective gel...

Jonathon Davidson

12 Aug 2025 13:21 (AEST)

ASX News Healthcare Biotechnology

Dual-listed across the NASDAQ and ASX, Neuren Pharma (ASX:NEU) has jumped +7% down under in the morning Thursday session as...

Jonathon Davidson

07 Aug 2025 11:41 (AEST)

ASX News Healthcare Biotechnology

The dangers of biotech were on display on Wednesday as Amplia Therapeutics (ASX:ATX), developing a cancer treatment called ACCENT, has failed to meet market expectations on the Wednesday session.

Jonathon Davidson

06 Aug 2025 12:08 (AEST)

ASX News Healthcare Biotechnology

At its annual shareholders meeting in Auckland today, AFT Pharmaceuticals (ASX:AFP) laid out its plans to leverage the company’s R@D pipeline as it hunts out new addressable markets worth as much as US$8 billion.Listen to the HotCopper podcast for in-depth discussions and insights...

01 Aug 2025 11:00 (AEST)

ASX News The Watchlist Healthcare Biotechnology

Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...

30 Jul 2025 12:48 (AEST)

ASX News Healthcare Biotechnology

Clinical-stage biotech and mental health innovator Emyria Limited (ASX:EMD) has fired up its national expansion strategy by signing a landmark agreement with Avive Health, a growing private hospital operator, to establish its first Empax clinic in Queensland.Under the agreement, Emyria will integ...

29 Jul 2025 12:05 (AEST)

ASX News Healthcare Biotechnology

Telix Pharma (ASX:TLX), the ASX listed healthcare major that once almost listed on the NASDAQ outright before...

Jonathon Davidson

23 Jul 2025 13:31 (AEST)

ASX News Healthcare Biotechnology